Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit
SOUTH SAN FRANCISCO, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO)…
Month: May 2021
Sunshine Biopharma Reports Improved Cash Position in 2021Q1 Filing
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Innovation Pharma Files Form 10-Q; Patient Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 Tops 70 Percent
WAKEFIELD, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
CymaBay Welcomes Dennis D. Kim, MD, MBA as Chief Medical Officer
Experienced Biotech Executive, Physician-Scientist and Orphan Disease Expert to Lead Clinical/Medical Functions as Seladelpar Advances…
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
Spero Therapeutics to Participate at the Berenberg Conference USA
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset…
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
SEL-399 (empty AAV8 capsid with ImmTOR) study on track with topline data expected in the…
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
Sunshine Biopharma Reports Improved Cash Position in 2021Q1 Filing
MONTREAL, May 13, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical…
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
Raised net proceeds of $27.9 million in U.S. initial public offering in February 2021 Lead…
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
Kura Oncology to Participate in Cowen Virtual Oncology Innovation Summit
SAN DIEGO, May 13, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage…
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
Acerus Reports First Quarter 2021 Financial Results
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
OpGen Reports First Quarter 2021 Financial Results and Provides Business Update
Total Revenue for Q1 2021 was approximately $0.8 million Balance sheet strengthened significantly with an…
Acerus Reports First Quarter 2021 Financial Results
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
Acerus Reports First Quarter 2021 Financial Results
TORONTO, May 13, 2021 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…